33 programming-"the"-"DAAD"-"Diamond-Light-Source"-"FEMTO-ST"-"Dr"-"U" "UCL" Fellowship positions
Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
About us The UCL Institute for Global Health (IGH) is at the heart of UCL’s Grand Challenge of Global Health. The Institute’s vision is for a world where international policy on global health is
-
. UCL is ranked 9th in the 2024 QS World University Rankings, 2nd in the UK for research power (Research Excellence Framework 2021) and our Neuroscience degree is ranked first in Europe (U.S. News and
-
. UCL is ranked 9th in the 2024 QS World University Rankings, 2nd in the UK for research power (Research Excellence Framework 2021) and our Neuroscience degree is ranked first in Europe (U.S. News and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The UCL Institute for Global Health (IGH) is at the heart of UCL’s Grand Challenge of Global Health. The Institute’s vision is for a world where international policy on global health is
-
About us UCL, based in Bloomsbury, is a welcoming, inclusive university situated at the heart of one of the world’s greatest cities. UCL is a top-ranked university in the UK for research in
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and